This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Université´ D'aix-Marseille. Active years: 2022.
Company Filing History:
1 out of 5,383 
1 out of 1,853 
1 out of 236 
Years Active: 2022
Title: Philippe Pierre: Innovator in Immunosuppressive Treatments
Introduction
Philippe Pierre is a notable inventor based in Marseille, France. He has made significant contributions to the field of immunology through his innovative research and patenting activities. His work primarily focuses on treatments for inflammatory conditions and diseases requiring immunosuppressive activity.
Latest Patents
Philippe Pierre holds a patent titled "Inhibitors of the PP1/GADD34 complex for the treatment of a condition requiring an immunosuppressive activity." This invention addresses the treatment and prevention of diseases involving inflammatory conditions, such as sepsis and autoimmune diseases. The patent specifically relates to inhibitors that target the activity or formation of the PP1/GADD34 complex, which is crucial for managing conditions that require immunosuppressive or anti-inflammatory actions.
Career Highlights
Throughout his career, Philippe Pierre has been associated with prestigious institutions, including Université d'Aix-Marseille and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to collaborate with leading researchers and contribute to advancements in medical science.
Collaborations
Due to space constraints, the details of Philippe Pierre's collaborations will not be included.
Conclusion
Philippe Pierre's innovative work in immunosuppressive treatments highlights his commitment to advancing medical science and improving patient outcomes. His patent reflects a significant step forward in the treatment of inflammatory and autoimmune diseases.